Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study

医学 耐受性 帕金森病 匹兹堡睡眠质量指数 生活质量(医疗保健) 安慰剂 失眠症 物理疗法 睡眠障碍 不利影响 交叉研究 内科学 疾病 精神科 睡眠质量 替代医学 护理部 病理
作者
Valérie Cochen De Cock,Pauline Dodet,Smaranda Leu‐Semenescu,Cécile Aerts,Giovanni Castelnovo,Beatriz Abril,Sophie Drapier,Hélène Olivet,Anne-Gaëlle Corbillé,Laurène Leclair‐Visonneau,M. Sallansonnet-Froment,Marie Lebouteux,Mathieu Anheim,Élisabeth Ruppert,Nicolas Vitello,Alexandre Eusébio,Isabelle Lambert,Ana Marqués,Maria Livia Fantini,David Devos
出处
期刊:Lancet Neurology [Elsevier BV]
卷期号:21 (5): 428-437 被引量:69
标识
DOI:10.1016/s1474-4422(22)00085-0
摘要

Summary

Background

Insomnia is a frequent complaint of patients with Parkinson's disease, and it negatively affects quality of life. Drugs that improve both sleep and parkinsonism would be of major benefit to patients with Parkinson's disease-related insomnia. We aimed to test the safety and efficacy of subcutaneous night-time only apomorphine infusion in patients with Parkinson's disease and insomnia.

Methods

We did a randomised, multicentre, double-blind, placebo-controlled, crossover trial in 11 expert centres in Parkinson's disease and sleep centres in France. Participants aged 35–90 years with fluctuating Parkinson's disease and moderate to severe insomnia (Insomnia Severity Index score ≥15) were randomly assigned to either first receive night-time subcutaneous apomorphine (up to 5 mg/h) or matching placebo. Randomisation was done using a computer-generated plan in blocks of four, stratified by centre. This first intervention was followed by a 14-night washout period, then crossover to the other intervention. The treatment periods consisted of a 10-night titration phase followed by a 7-night fixed-dose phase. The dose was adjusted during the titration phase on the basis of a daily telephone call assessing sleep quality and treatment tolerability. The primary efficacy endpoint was the difference in Parkinson's disease sleep scale (PDSS) scores from the beginning to the end of each treatment period. Analysis was done on an intention-to-treat basis. This trial is registered with ClinicalTrials.gov, NCT02940912.

Findings

Between Jan 31, 2017, and Jan 29, 2021, 46 participants were enrolled. 25 (54%) patients were randomly assigned to receive apomorphine first and 21 (46%) patients to receive placebo first. Mean change in PDSS score was significantly greater with night-time apomorphine infusion (15·18 [SD 24·34]) compared with placebo (5·23 [21·52]; treatment effect 9·95 [95% CI 0·88–19·03]; p=0·041). Adverse events were reported in 25 (54%) participants during the apomorphine period and in 17 (37%) participants during the placebo period (p=0·16). Apomorphine was associated with more frequent dizziness than was placebo (seven [15%] vs 0; p=0·041).

Interpretation

Subcutaneous night-time only apomorphine infusion improved sleep disturbances according to difference on PDSS score, with an overall safety profile consistent with previous studies in Parkinson's disease. This treatment might be useful to manage sleep disturbances in patients with advanced Parkinson's disease and moderate to severe insomnia.

Funding

Orkyn and Aguettant Pharma.

Translation

For the French translation of the abstract see Supplementary Materials section.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
H奥利奥完成签到,获得积分10
刚刚
阿辉发布了新的文献求助10
1秒前
1秒前
打打的应助被知沐采纳,获得10
1秒前
66发布了新的文献求助10
2秒前
2秒前
Tanghx发布了新的文献求助10
5秒前
哈哈大王完成签到,获得积分10
5秒前
小马甲的应助被Ghy采纳,获得30
6秒前
盒子发布了新的文献求助10
6秒前
假唱卡带完成签到,获得积分10
7秒前
8秒前
jin的应助被南笙采纳,获得10
8秒前
DW的应助被yinba采纳,获得10
9秒前
9秒前
tangyong发布了新的文献求助10
10秒前
Criminology34的应助被yfz1175采纳,获得10
11秒前
11秒前
lyh完成签到,获得积分10
12秒前
852的应助被wzk采纳,获得10
12秒前
西大可怜虫完成签到,获得积分10
12秒前
13秒前
111发布了新的文献求助20
13秒前
惠飞薇发布了新的文献求助10
13秒前
大模型的应助被宋嘉新采纳,获得10
13秒前
13秒前
搜集达人的应助被不困还能肝采纳,获得10
14秒前
14秒前
14秒前
14秒前
14秒前
14秒前
15秒前
15秒前
15秒前
16秒前
赵云龙发布了新的文献求助10
16秒前
16秒前
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163536
求助须知:如何正确求助?哪些是违规求助? 9557611
关于积分的说明 21741159
捐赠科研通 7754159
什么是DOI,文献DOI怎么找? 3428214
关于科研通互助平台的介绍 2552969
邀请新用户注册赠送积分活动 2472918